I-Novartis Archives -

INGWAZI V600E, i-dabrafenib, I-Mekinist, melanoma, I-Novartis, I-Tafinlar, I-Trametinib

I-Dabrafenib ihlanganiswe ne-trametinib igunyazwe yi-FDA ngamathumba aqinile angabukeki noma ametastatic anokuguqulwa kwe-BRAF V600E

Julayi 2022: I-Dabrafenib (i-Tafinlar, i-Novartis) kanye ne-trametinib (i-Mekinist, i-Novartis) zithole ukugunyazwa okusheshisiwe okuvela ku-Food and Drug Administration yokwelapha iziguli zabantu abadala kanye nezingane ezindala kuneminyaka engu-6 ubudala nezingenayo.

Isivivinyo se-ELARA, i-follicular lymphoma, UKymriah, I-NCT03568461, I-Novartis, Ukulinganisa kwenkampani Novartis Pharmaceuticals Corporation, Unyusibhabha

I-Tisagenlecleucel igunyazwe yi-FDA nge-lymphoma ebuyele emuva noma e-refractory follicular

Juni 2022: Ngemva kwemigqa emibili noma ngaphezulu yokwelashwa kwe-systemic, i-FDA yaklomelisa i-tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) yagunyaza ngokushesha iziguli ezikhulile ezine-lymphoma ebuyelelwe emuva noma e-refractory follicular (FL).T..

gallium Ga 68 gozetotide, I-Locametz, lutetium Lu 177 vipivotide tetraxetan, mCRPC, I-Novartis, Pluvicto, I-PSMA

U-Pluvicto ugunyazwe yi-FDA ngomdlavuza wendlala yesinye we-metastatic castration-resistant

Ephreli 2022: Ukuphathwa Kwezokudla Nezidakamizwa kugunyaze i-Pluvicto (lutetium Lu 177 vipivotide tetraxetan, Advanced Accelerator Applications USA, Inc., inkampani yakwaNovartis) ukuze kulashwe iziguli ezikhulile ezine-prostate-specific mem.

i-cytokine release syndrome, UJill O'Donnell-Tormey, UKymriah, I-Novartis

Ukwelashwa kwamaseli e-CAR-T kungenziwa kuphephe futhi kutholakale kabanzi ngokulungiswa okumbalwa

Mashi 2022: Indlela eguquguqukayo yokwelashwa kwe-CAR-T Cell inamandla okugumbuqela lokho osekuyi-axiom yezokwelapha: ukuthi umphumela omangalisayo wokwelashwa kumathumba ufika ngenani lezingozi ezinkulu ezigulini.

I-Kite, UKymriah, I-Novartis, Yeskarta

Ukwelashwa kwe-CAR NK kunesilinganiso esisebenzayo esingu-73%

I-Immunotherapy ekwelapheni umdlavuzaUkwelashwa kwe-CAR-NK kunesilinganiso esisebenzayo esingu-73%, futhi kuqashwa ezivivinyweni zomtholampilo zasekhaya.I-Immunotherapy iguqule indlela olashwa ngayo umdlavuza. I-Cancer immunotherapy ihlukaniswe..

I-Tag: Novartis

Ikhaya / Unyaka Omisiwe

INGWAZI V600E, i-dabrafenib, I-Mekinist, melanoma, I-Novartis, I-Tafinlar, I-Trametinib

I-Dabrafenib ihlanganiswe ne-trametinib igunyazwe yi-FDA ngamathumba aqinile angabukeki noma ametastatic anokuguqulwa kwe-BRAF V600E

Isivivinyo se-ELARA, i-follicular lymphoma, UKymriah, I-NCT03568461, I-Novartis, Ukulinganisa kwenkampani Novartis Pharmaceuticals Corporation, Unyusibhabha

I-Tisagenlecleucel igunyazwe yi-FDA nge-lymphoma ebuyele emuva noma e-refractory follicular

gallium Ga 68 gozetotide, I-Locametz, lutetium Lu 177 vipivotide tetraxetan, mCRPC, I-Novartis, Pluvicto, I-PSMA

U-Pluvicto ugunyazwe yi-FDA ngomdlavuza wendlala yesinye we-metastatic castration-resistant

i-cytokine release syndrome, UJill O'Donnell-Tormey, UKymriah, I-Novartis

Ukwelashwa kwamaseli e-CAR-T kungenziwa kuphephe futhi kutholakale kabanzi ngokulungiswa okumbalwa

I-Kite, UKymriah, I-Novartis, Yeskarta

Ukwelashwa kwe-CAR NK kunesilinganiso esisebenzayo esingu-73%

Ulwazi

Ukwelashwa

I-united states

India

China

Iran

Dubai